36
Participants
Start Date
September 1, 2020
Primary Completion Date
September 30, 2026
Study Completion Date
October 31, 2026
IRDye800CW-nimotuzumab
50 mg of IRDye800CW-nimotuzumab will be infused intravenously over a period of 30 minutes. Lung cancer resection surgery will be done at different time points post infusion
RECRUITING
St. Paul's Hospital, Saskatoon
Western Economic Diversification Canada
OTHER_GOV
University of Saskatchewan
OTHER